https://en.wikipedia.org/wiki/Tabernanthe_iboga
Legal status[edit]
Iboga is outlawed or restricted in Belgium, Poland, Denmark, Croatia, France,[6] Sweden, and Switzerland. In the United States Iboga is classified by the Controlled Substances Act on thelist of schedule I drugs.[1][2]
Non-profit organization Föreningen för hollistisk missbruksvård (ibogain.se) is trying to convince the Swedish government to start up clinical investigations of its anti-addictive properties, loosen up the prohibition law against ibogaine, and allow the creation of treatment facilities in Sweden.
Exportation of iboga from Gabon is illegal since the passage of a 1994 cultural protection law.[7]
Shredded bark of Tabernanthe iboga for consumption. Contains ibogaine.
Conservation status[edit]
While little data is available on the exploitation and existing habitat of the iboga plant, the destructive effects of harvesting and slow growth could have already severely damaged the wild iboga population.[8]
Patents and applications[edit]
Here is a selection of iboga patents and patent applications filed in the last decade[1]US Patent or Application Number Title Owner/ Inventor Comment Application 20050288375,published 29 December 2005 Method and composition for treating neurodegenerative disorders Myriad Genetics,Salt Lake City, UT US Claims ibogaine (and other compounds) used with an NSAID “for treating and preventing neurodegenerative disorders like Alzheimer's disease, dementia, mild cognitive impairment." Application 20050222270 published 6 October 2005 and patent 5,958,919, issued 28 September 1999, and others Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis Washington University, St.Louis, MO US Use of ibogaine to enhance safety in a technique to “ease problems such as addictions to illegal or pain-killing drugs, nicotine, or alcohol, compulsive or criminal behavioral problems, severe depression, obsessive-compulsive disorders, phobias, etc." Patent 6,416,793,issued 9 July 2002 Formulations and use of controlled-release indolealkaloids BioResponse,LLC, Boulder, CO, US Ibogaine (and yohimbe) formulations with enhanced absorption by the body Patent 6,348,456,issued 19 February 2002, and Application 20030153552,published 14 August 2003 Method of treating chemical dependency in mammals and a composition therefor Mash; Deborah C. (University of Miami professor)and co-inventors Claims noribogaine, a variant of ibogaine suitable for pharmaceuticals, and its use to treat addiction to “heroin, cocaine, alcohol, nicotine, amphetamine, methamphetamine, opium, methadone, hycodan, morphine and caffeine." Patent 6,211,360, issued 3 April 2001 Ibogamine cogeners Albany Medical College (Albany,NY, US) and the University of Vermont (US). Ibogamine-derived compounds for treating drug addiction Patent 5,616,575, issued 1 April 1997 Bioactive tricyclicibogaine analogs University of Minnesota, US and University of Miami, US Ibogamine-derived compounds for treating drug addiction
Documentary films about iboga[edit]
See also: List of films about ibogaine therapy
Iboga, les hommes du bois sacré (2002)
In this French-language film, Gilbert Kelner documents modern Bwiti practices and Babongo perspectives on iboga. Odisea broadcast a Spanish-dubbed version titled Los hombres de la madera ("The Men of the Wood").
Ibogaine: Rite of Passage (2004)
Directed by Ben Deloenen.[9] A 34-year-old heroin addict undergoes ibogaine treatment with Dr Martin Polanco at the Ibogaine Association, a clinic in Rosarito Mexico. Deloenen interviews people formerly addicted to heroin, cocaine, and methamphetamine, who share their perspectives about ibogaine treatment. In Gabon, a Babongo woman receives iboga root for her depressive malaise. Deloenen visually contrasts this Western, clinical use of ibogaine with the Bwiti use of iboga root bark, but emphasizes the Western context.
"Babongo" (2005)
In this episode (series 1, episode 4) of the English documentary series Tribe, presenter Bruce Parry ingests iboga during his time with the Babongo. BBC 2 aired the episode on 25 January 2005.[1
Iboga is outlawed or restricted in Belgium, Poland, Denmark, Croatia, France,[6] Sweden, and Switzerland. In the United States Iboga is classified by the Controlled Substances Act on thelist of schedule I drugs.[1][2]
Non-profit organization Föreningen för hollistisk missbruksvård (ibogain.se) is trying to convince the Swedish government to start up clinical investigations of its anti-addictive properties, loosen up the prohibition law against ibogaine, and allow the creation of treatment facilities in Sweden.
Exportation of iboga from Gabon is illegal since the passage of a 1994 cultural protection law.[7]
Shredded bark of Tabernanthe iboga for consumption. Contains ibogaine.Conservation status[edit]
While little data is available on the exploitation and existing habitat of the iboga plant, the destructive effects of harvesting and slow growth could have already severely damaged the wild iboga population.[8]
Patents and applications[edit]
Here is a selection of iboga patents and patent applications filed in the last decade[1]
| US Patent or Application Number | Title | Owner/ Inventor | Comment |
|---|---|---|---|
| Application 20050288375,published 29 December 2005 | Method and composition for treating neurodegenerative disorders | Myriad Genetics,Salt Lake City, UT US | Claims ibogaine (and other compounds) used with an NSAID “for treating and preventing neurodegenerative disorders like Alzheimer's disease, dementia, mild cognitive impairment." |
| Application 20050222270 published 6 October 2005 and patent 5,958,919, issued 28 September 1999, and others | Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis | Washington University, St.Louis, MO US | Use of ibogaine to enhance safety in a technique to “ease problems such as addictions to illegal or pain-killing drugs, nicotine, or alcohol, compulsive or criminal behavioral problems, severe depression, obsessive-compulsive disorders, phobias, etc." |
| Patent 6,416,793,issued 9 July 2002 | Formulations and use of controlled-release indolealkaloids | BioResponse,LLC, Boulder, CO, US | Ibogaine (and yohimbe) formulations with enhanced absorption by the body |
| Patent 6,348,456,issued 19 February 2002, and Application 20030153552,published 14 August 2003 | Method of treating chemical dependency in mammals and a composition therefor | Mash; Deborah C. (University of Miami professor)and co-inventors | Claims noribogaine, a variant of ibogaine suitable for pharmaceuticals, and its use to treat addiction to “heroin, cocaine, alcohol, nicotine, amphetamine, methamphetamine, opium, methadone, hycodan, morphine and caffeine." |
| Patent 6,211,360, issued 3 April 2001 | Ibogamine cogeners | Albany Medical College (Albany,NY, US) and the University of Vermont (US). | Ibogamine-derived compounds for treating drug addiction |
| Patent 5,616,575, issued 1 April 1997 | Bioactive tricyclicibogaine analogs | University of Minnesota, US and University of Miami, US | Ibogamine-derived compounds for treating drug addiction |
See also: List of films about ibogaine therapy
Iboga, les hommes du bois sacré (2002)
In this French-language film, Gilbert Kelner documents modern Bwiti practices and Babongo perspectives on iboga. Odisea broadcast a Spanish-dubbed version titled Los hombres de la madera ("The Men of the Wood").
Ibogaine: Rite of Passage (2004)
Directed by Ben Deloenen.[9] A 34-year-old heroin addict undergoes ibogaine treatment with Dr Martin Polanco at the Ibogaine Association, a clinic in Rosarito Mexico. Deloenen interviews people formerly addicted to heroin, cocaine, and methamphetamine, who share their perspectives about ibogaine treatment. In Gabon, a Babongo woman receives iboga root for her depressive malaise. Deloenen visually contrasts this Western, clinical use of ibogaine with the Bwiti use of iboga root bark, but emphasizes the Western context.
"Babongo" (2005)
In this episode (series 1, episode 4) of the English documentary series Tribe, presenter Bruce Parry ingests iboga during his time with the Babongo. BBC 2 aired the episode on 25 January 2005.[1